Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) EBT (2021 - 2025)

Historic EBT for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to -$146.5 million.

  • Core Scientific's EBT rose 6780.34% to -$146.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$767.4 million, marking a year-over-year increase of 3832.51%. This contributed to the annual value of -$1.3 billion for FY2024, which is 43463.17% down from last year.
  • According to the latest figures from Q3 2025, Core Scientific's EBT is -$146.5 million, which was up 6780.34% from -$936.6 million recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's EBT peaked at $580.9 million during Q1 2025, and registered a low of -$936.6 million during Q2 2025.
  • Its 5-year average for EBT is -$219.1 million, with a median of -$146.5 million in 2025.
  • As far as peak fluctuations go, Core Scientific's EBT plummeted by 2596568.57% in 2022, and later skyrocketed by 7435950.7% in 2024.
  • Quarter analysis of 5 years shows Core Scientific's EBT stood at $77.0 million in 2021, then tumbled by 692.91% to -$456.3 million in 2022, then soared by 57.19% to -$195.4 million in 2023, then tumbled by 35.73% to -$265.2 million in 2024, then soared by 44.74% to -$146.5 million in 2025.
  • Its EBT was -$146.5 million in Q3 2025, compared to -$936.6 million in Q2 2025 and $580.9 million in Q1 2025.